TROG Cancer Research
Members Login   CQMS Login  

How your donation helps

As the premier Australasian body for radiotherapy research, TROG Cancer Research aims to improve outcomes and quality of life for all cancer patients that can utilise radiotherapy as part of their treatment. There are many types of cancers that can be treated with radiotherapy such as breast, lung, prostate, skin, head and neck, gynaecological, gastrointestinal and more.

With your support TROG is able to build on its formidable research record. Since 1989, TROG has launched more than 90 clinical trials with more than 14,000 cancer patients taking part.

We currently need funding to initiate research.

All research starts with an idea. When a radiation oncologist has an idea for a research project, there are several processes that must happen before a trial is approved. This first year is referred to as a 'trial in development' and includes developing the trial protocol; ethics review; and peer review. In many ways this period is the most critical to the success of a trial, yet is not covered by government funding. Please contact us if you wish your donation to support this critical part of the research process.

Where your donation currently helps

Your donation helps TROG fulfil many daily research activities, including:

  • ensuring patient safety is monitored during the trial
  • developing protocols for our researchers
  • arranging ongoing peer review
  • developing Quality Assurance requirements that will be applied continuously throughout the life of the trial
  • ensuring all the indemnity, contractual and regulatory documentation for a trial is complete
  • patient and trial record keeping 
  • ensuring a trial complies with strict international Good Clinical Practice standards
  • reporting timelines to regulatory agencies

Cancer research projects you can help fund now

TROG also undertakes other projects that support the running of clinical trials; below is an example for which we are currently seeking funding.

Post recruitment analysis

TROG is generally successful in seeking funding for the conduct of a trial; this is achieved mainly through the assistance of major funding bodies such as Cancer Australia.

Generating funding for analysis and patient follow-ups, however, is difficult. Follow-ups are vital as they allow patients to be monitored by their radiation oncologist for 2, 5, 10 and 20 years after the trial has been completed. Many patients see this as one of the benefits of taking part in a clinical trial since it provides substantial additional care. Please let us know if you would like your donation to be directed toward this beneficial process for patients.

Donate now

It's easy to donate - simply download our donation form or donate online.

TROG has been improving the outcomes of cancer patients for almost 30 years.